News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.
The deal allows St. Louis-based Canopy to access Cosmo's Japanese academic and pharma customers for its gene editing and personalized medicine technologies.
The company said its proxy-CRISPR tool can facilitate precise gene editing and eliminates the need for genetic engineering of naturally occurring CRISPR proteins.
Taconic Biosciences said that it will use ERS Genomics' CRISPR-Cas9 technology to generate unique murine models.
Designing successful gene drives using CRISPR will require that researchers characterize the genetic variability and mating systems of target populations.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.